HL Weiner, JA Cohen - Multiple sclerosis, 2002 - msj.sagepub.com HL Weiner* ,1 and JA Cohen 2 1 Multiple Sclerosis Center, Brigham and Women's
Hospital, Massachusetts General Hospital, Harvard Medical School, 333 Longwood
Avenue, Boston, Massachusetts 02115, USA; Cited by 70 - Related articles - BL Direct - All 3 versions
MG Attur, R Patel, G Thakker, P Vyas, D … - Inflammation Research, 2000 - Springer Abstract. Objective and Design: Cyclosporin, FK-506 and rapamycin have similar
but distinct modes of interaction with cyclophilins, calcineurins and
transcription factors. These immunosuppressive drugs have also been shown ... Cited by 54 - Related articles - BL Direct - All 2 versions
D Vassilopoulos, C Camisa, RM Strauss - Rheumatic Disease Clinics of North America, 1999 - Elsevier Rheumatologists treating patients with various rheumatic diseases are often
faced with challenging clinical situations in which the available treatment
options can adversely influence the course of a coexistent disease. The ... Cited by 11 - Related articles - BL Direct - All 17 versions
PA Brogan, MJ Dillon - British Medical Journal, 2000 - adc.bmj.com Cytotoxic drugs prevent cell division or cause cell death. 1 They act
predominantly on rapidly dividing cells such as T lymphocytes, and are therefore
immunosuppressive and anti-inflammatory. 1 When cytotoxic drugs were ... Cited by 12 - Related articles - BL Direct - All 11 versions
- ►mynrma.com.au [PDF] C Pagnoux, A Mahr, MA Hamidou, JJ Boffa, M … - New England Journal of Medicine, 2008 - content.nejm.org From Université Paris Descartes, Hôpital Cochin, Assistance
Publique–Hôpitaux de Paris (CP, AM, PC, LM, LG), Hôpi- tal Tenon (J.-JB),
and Hôpital Bichat– Claude-Bernard (TP) — all in Paris; Cen- tre ... Cited by 13 - Related articles - All 7 versions
D Aud, SL Peng - Nature clinical practice. Rheumatology, 2006 - ncbi.nlm.nih.gov Studies on the pathogenesis of inflammatory arthritides have begun to delve into
the molecular and cellular mechanisms behind the development of these diseases,
and transcription factors, as key regulators of immune-effector-cell ... Cited by 11 - Related articles - BL Direct - All 3 versions
F Kees, G Mair, M Dittmar, M Bucher - Transplantation proceedings, 2004 - Elsevier The bioavailability of cyclosporine a (CyA) was assessed in 2 cross-over studies
with 12 healthy male volunteers each. Study A compared the bioavailability of
Cicloral (test) with the microemulsion Neoral (reference) in the fasting ... Cited by 9 - Related articles - All 10 versions
WL Gross - Der Internist, 1999 - Springer Die Behandlung der primär systemischen Vaskulitiden (PSV) ist heute
außerordentlich dif- ferenziert.Sie wird im akuten Stadium von der definitiven
Diagnose (Krankheitsentität), der Ausdehnung und Aktivität der Erkrankung ... Cited by 18 - Related articles - BL Direct - All 2 versions
T Hirano - International immunopharmacology, 2007 - Elsevier The therapeutic effects of immunosuppressive drugs are known to deviate largely
between patients, but efficient strategies for the differentiation of patients
who show clinical resistance to immunosuppressive therapies have not been ... Cited by 6 - Related articles - All 4 versions
